Stem Cell Transplant Complications Recruiting Phase 4 Trials for Ruxolitinib (DB08877)

IndicationStatusPhase
DBCOND0081111 (Stem Cell Transplant Complications)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs